Skip to main content

Part of the book series: Argenteuil Symposia ((ARGENTEUIL))

Abstract

The selection of rheumatic fever as the introductory topic for this volume may or may not be appropriate. On the one hand, few diseases have done more to stimulate the concept of “molecular mimicry” in autoimmunity. On the other hand, autoimmunity remains so far but a popular concept for the pathogenesis of this disease and is not the proven pathogenetic mechanism. The methodology of immunology has become increasingly powerful, however, and it may now be possible to identify on a molecular basis which (if any) of the group A streptococcal epitopes that are cross-reactive with human tissues are, or are not, relevant to the cardiac injury of the disease. It is this cardiac injury that makes rheumatic fever so important to the human race, and particularly to the medically neglected communities of the world [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Stollerman GH (1975) Rheumatic fever and streptococcal infection. Grune and Stratton, New York

    Google Scholar 

  2. Zabriskie JB, Freimer EH (1966) An immunological relationship between the group A streptococcus and mammalian muscle. J Exp Med 124: 661–678

    Article  PubMed  CAS  Google Scholar 

  3. Nahr GM, Majeed HA, Yousof aAM, Chedid L, Behbehami K (1986) Detection of antibodies to muramyl dipeptide ( MDP) the, adjuvant moiety of streptococcal cell wall, in patients with rheumatic fever. J Infect Dis 154: 1012–1017

    Article  Google Scholar 

  4. Dudding BA, Ayoub EM (1968) Persistence of streptococcal Group A antibody in patients with rheumatic valvular disease. J Exp Med 128: 1081–1098

    Article  PubMed  CAS  Google Scholar 

  5. Beachey EH, Ofek I (1976) Epithelial cell binding of group A streptococcal by lipoteichoic acid on fimbriae denuded of M protein. J Exp Med 143: 759–771

    Article  PubMed  CAS  Google Scholar 

  6. Coburn AF, Pauli RH (1935) Studies on the immune response of the rheumatic subject and its relationship to activity and non-effective process. IV. Characteristics of strains of hemolytic streptococcus, effretive and non-effective in initiating rheumatic activity. J Clin Invest 14: 755–762

    Article  PubMed  CAS  Google Scholar 

  7. Kuttner AG, Krumwiede E (1941) Observations on the effect of streptococcal upper respiratory infections in rheumatic children. A three-year study. J Clin Invest 20: 273–287

    Article  PubMed  CAS  Google Scholar 

  8. Stollerman GH (1969) Nephritogenic and rheumatogenic group A streptococci. J Infect Dis 120: 258–263

    Article  PubMed  CAS  Google Scholar 

  9. Wannamaker LW (1970) Medical progress. Differences between streptococcal infections of the throat and of the skin. N Engl J Med 282:23–30, 78–85

    Google Scholar 

  10. Stollerman GH (1975) The relative rheumatogenicity of strains of group A streptococci. Mod Concept Cardiovasc Dis 44: 35–40

    CAS  Google Scholar 

  11. Dillon HC (1972) Streptococcal infections of the skin and their complications: impetigo and nephritis. In: Wannamaker LW, Milton JM (eds) Streptococci and streptococcal diseases. Academic Press, New York, pp 571–587

    Google Scholar 

  12. Wannamaker LW (1973) The chain that links the heart to the throat. Circulation 48: 9–18

    PubMed  CAS  Google Scholar 

  13. Stollerman GH (1961) Factors determining the attack rate of rheumatic fever. J Am Med Ass 177: 823–828

    Google Scholar 

  14. Stetson CA (1954) The relation of antibody response to rheumatic fever. In: McCarthy M (ed) Streptococcal infections. Columbia University Press, New York, pp 208–218

    Google Scholar 

  15. Siegel AC, Johnson EE, Stollerman GH (1961) Controlled studies of streptococcal pharyngitis in a pediatric population: I. Factors related to the attack rate of rheumatic fever. N Engl J Med 265: 559–566

    Article  Google Scholar 

  16. Holmberg SD, Faich GA (1983) Streptococcal pharyngitis and acute rheumatic fever in Rhode Island. J Am Med Ass 250: 2307–2312

    Article  CAS  Google Scholar 

  17. Bisno AL (1980) The concept of rheumatogenic and non-rheumatogenic group A streptococci. In: Read SE, Zabriskie JB (eds) Streptococcal diseases and the immune response. Academic Press, New York, pp 789–803

    Google Scholar 

  18. Bessen D, Jones KF, Fischetti VA (1989) Evidence for two distinct classes of streptococcal M- protein and their relationship to rheumatic fever. J Exp Med 169: 269–283

    Article  PubMed  CAS  Google Scholar 

  19. Dale JB, Beachey EH (1986) Sequence of myosin cross-reactive epitopes of streptococcal M protein. J Exp Med 164:1785 –1790

    Google Scholar 

  20. Krisher K, Cunningham MW (1985) Myosin: a link between streptococci and heart. Science 227: 413–41

    Article  PubMed  CAS  Google Scholar 

  21. Widdowson JP, Maxted WR, Grant DL (1970) The production of opacity in serum by group A streptococci and its relationship with the presence of M antigen. J Gen Microbiol 61: 343–353

    PubMed  CAS  Google Scholar 

  22. Veasy LG, Wiedmeier SE, Orsmond GS et al. (1987) Resurgence of acute rheumatic fever in the intermountain area of the United States. N Engl J Med 316: 421–427

    Article  PubMed  CAS  Google Scholar 

  23. Centers for Disease Control (1987) Acute rheumatic fever — Utah. MMWR 36 (9): 108

    Google Scholar 

  24. Congeni B, Rizzo C, Congeni J, Screenivasan W (1987) Outbreak of acute rheumatic fever in Northeast Ohio. J Pediat 111: 176–179

    Article  PubMed  CAS  Google Scholar 

  25. Wald ER, Dashefsky B, Feidt CL et al. (1987) Acute rheumatic fever in Western Pennsylvania and the Tri-state Area. Pediatrics 80: 371–374

    PubMed  CAS  Google Scholar 

  26. Centers for Disease Control (1988) Acute rheumatic fever at a Navy training center — San Diego, California. MMWR 37: 101

    Google Scholar 

  27. Centers for Disease Control (1988) Acute rheumatic fever among Army trainees — Fort Leonard Wood, MO, 1987-1988. MMWR 37: 519–522

    Google Scholar 

  28. Marcon MJ, Hribar MM, Hosier DM et al. (1988) Occurrence of mucoid M-18 Streptococcus pyogenes in a Central Ohio pediatric population. J Clin Microbiol 26: 1539–1542

    PubMed  CAS  Google Scholar 

  29. Kaplan EL, Johnson DR, Cleary PP (1989) Group A streptococcal serotypes isolated from patients and sibling contacts during the resurgence of rheumatic fever in the United States in the mid-1980s. J Infect Dis 159: 101–103

    Article  PubMed  CAS  Google Scholar 

  30. Stevens DL, Tanner MH, Winship J et al. (1989) Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 321: 1–7

    Article  PubMed  CAS  Google Scholar 

  31. Johnson LP, L’ltalier JJ, Schlievert PM (1986) Streptococcal pyrogenie exotoxin type A (scarlet fever toxin) is related to Staphylococcus aureus entertoxin B. MGG 203: 354–356

    Google Scholar 

  32. Ayoub EM, Taranta A, Bartley TD (1974) Effect of valvular surgery on antibody to the group A streptococcal carbohydrate. Circulation 50: 144–150

    PubMed  CAS  Google Scholar 

  33. Stollerman GH (1987) Autoimmunity and rheumatic fever. In: Cohen IR (ed) Perspectives on autoimmunity. CRC Press, Boca Raton, FL, pp 143–153

    Google Scholar 

  34. Cavelti PA (1945) Autoantibodies in rheumatic fever. Proc Soc Exp Biol Med 60: 379–381

    PubMed  CAS  Google Scholar 

  35. Coons AH, Kaplan MH (1950) Localization of antigen in tissue cells. II. Improvements in a method for the detection of antigen by means of fluorescent antibody. J Exp Med 91: 1–13

    Article  PubMed  CAS  Google Scholar 

  36. Kaplan MH, Suchy ML (1964) Immunological relation of streptococcal and tissue antigens. II. Cross-reactions of antisera to mammalian heart tissue with a cell wall constituent of certain strains of group A streptococci. J Exp Med 119: 643–650

    Article  PubMed  CAS  Google Scholar 

  37. Kaplan MH, Svec KH (1964) Immunologic relation of streptococcal antibody cross-reactive with heart tissue. Association with streptococcal infection, rheumatic fever and glomerulonephritis. J Exp Med 119: 651–666

    Article  PubMed  CAS  Google Scholar 

  38. Kaplan MH (1969) Cross-reaction of group A streptococci and heart tissue: Varying serologic specificity of cross-reactive antisera and relation to carrier-hapten specificity. Transplant Proc 1: 976–980

    PubMed  CAS  Google Scholar 

  39. Beachey EH, Stollerman GH (1973) Mediation of cytotoxic effects of streptococcal M protein by non-type specific antibody in human sera. J Clin Invest 52: 2563–2570

    Article  PubMed  CAS  Google Scholar 

  40. Cunningham M, Beachey EH (1975) Immunochemical properties of streptococcal M protein purified by isoelectric focusing. J Immunol 115: 1002–1006

    PubMed  CAS  Google Scholar 

  41. Beachey EH, Stollerman GH, Chiang EY, et al. (1977) Purification and properties of M protein extracted from group A streptococci with pepsin. Covalent structure of the amino terminal region of type 24 M antigen. J Exp Med 145: 1469–1483

    Article  PubMed  CAS  Google Scholar 

  42. Beachey EH, Tartar A, Seyer JM, Chedid L (1984) Epitope-specific protective immunogenicity of chemically synthesized 13-, 18-, and 23-residue peptide fragments of streptococcal M protein. Proc Natl Acad Sci USA 81: 2203–2207

    Article  PubMed  CAS  Google Scholar 

  43. Dale JB, Beachey EH (1986) Localization of protective epitopes of the amino acid terminus of type 5 streptococcal M protein. J Exp Med 163: 1191–1202

    Article  PubMed  CAS  Google Scholar 

  44. Cunningham MW, Swerlick RA (1987) Poly specificity of antistreptococeal murine monoclonal antibodies and their implications in autoimmunity. J Exp Med 164: 998–1012

    Article  Google Scholar 

  45. Cairnes LM (1987) Immunological studies in rheumatic fever. The immunology of rheumatic fever. N Z Med J 101: 388–391

    Google Scholar 

  46. Bronze MS, Beachey EH, Dale JB (1988) Protective and heart cross-reactive epitopes located within the NH2 terminus of type 19 streptococcal M protein. J Exp Med 167: 1849–1859

    Article  PubMed  CAS  Google Scholar 

  47. Manjula BN, Trus BL, Fischetti VA (1985) Presence of two distinct regions in the coiled-coil structure of the streptococcal pep M5 protein relationship to mammalian coiled-coil proteins and implications to its biological properties. Proc Natl Acad Sci USA 82: 1064–1068

    Article  PubMed  CAS  Google Scholar 

  48. Goldstein I, Halpern B, Robert L (1967) Immunological relationship between streptococcus A polysaccharide and the structural glycoproteins of heart valve. Nature 213: 44–47

    Article  CAS  Google Scholar 

  49. Dorling J, Kingston J (1976) Anti-streptococcal antibodies reacting with brain tissue. II. Ultrastructural studies. Br J Exp Path 57: 255–265

    Google Scholar 

  50. Husby G, van de Rijn I, Zabriskie J, Abdin Z, Williams R Jr (1976) Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever. J Exp Med 144: 1094–1110

    Article  PubMed  CAS  Google Scholar 

  51. McKeon FD, Kirschner MW, Caput D (1986) Homologies in both primary and secondary structure between nuclear envelope and intermediate filament proteins. Nature 319: 463–468

    Article  PubMed  CAS  Google Scholar 

  52. Sandson J, Hamerman D, Janis R, Rojkind M (1968) Immunologic chemical similarities between the streptococcus and human connective tissue. Trans Ass Am Physns 81: 249–257

    CAS  Google Scholar 

  53. Fillit HM, Blake M, MacDonald C, McCarthy M (1988) Immunogenicity of liposome-bound hyaluronate in mice. J Exp Med 168: 971–982

    Article  PubMed  CAS  Google Scholar 

  54. Zabriskie JB, Hsu KC, Seegal BC (1970) Heart-reactive antibody associated with rheumatic fever: characterization and diagnostic significance. Clin Exp Immunol 7:147 –159

    Google Scholar 

  55. Chase RM, Rapaport FT (1965) The bacterial indirection of homograft sensitivity. I. Effects of sensitization with group A streptococci. J Exp Med 122: 721–732

    Google Scholar 

  56. Read SE, Fischetti VA, Utermohlen V, Falk RE, Zabriskie JB (1974) Cellular reactivity studies to streptococcal antigens. Migration inhibition studies in patients with streptococcal infections and rheumatic fever. J Clin Invest 54: 439–450

    Article  PubMed  CAS  Google Scholar 

  57. Leuker RD, Abdin ZH, Williams RC Jr (1975) Peripheral blood T and B lymphocytes during acute rheumatic fever. J Clin Invest 55: 975–985

    Article  Google Scholar 

  58. Yang LC, Soprey PR, Wittner MK, Fox EN (1977) Streptococcal-induced cell-mediated immune destruction of cardiac myofibers in vitro. J Exp Med 146: 344–360

    Article  PubMed  CAS  Google Scholar 

  59. Senitzer D, Cafrumy W, Pansky B, Freimer EH (1977) Spontaneous and induced cell-mediated reactivity to syngenic cells. Nature 268: 158–159

    Article  PubMed  CAS  Google Scholar 

  60. Williams RC Jr, Raizada V, Prakash K, van de Rijn I, Zabriskie JB, Stobo JD, Sharma KB (1982) Changes in T-lymphocyte subsets during acute rheumatic fever. J Clin Immunol 2: 166–172

    Article  PubMed  Google Scholar 

  61. Gray ED, Wannamaker LW, Ayoub EM, Elkholy A, Abdin ZH (1981) Cellular immune responses to extracellular streptococcal products in rheumatic heart disease. J Clin Invest 68: 665–671

    Article  PubMed  CAS  Google Scholar 

  62. Shiokawa Y, Iida V, Taniguchi K (1978) Cellular immunity in rheumatic heart disease. Jpn Circ J 42: 39–42

    Article  PubMed  CAS  Google Scholar 

  63. Amoils B, Morrison RC, Wadee AA et al. (1986) Aberrant expression of HLA-DR antigen on valve fibroblast from patients with active rheumatic carditis. Clin Exp Immunol 66:88 –94

    PubMed  CAS  Google Scholar 

  64. Kotb M, Dale JB, Beachey EH (1987) Stimulation of S-adenosylmethionine synthetase in human lymphocytes in streptococcal M protein. J Immunol 139: 202–206

    PubMed  CAS  Google Scholar 

  65. Ayoub EM, Barrett DJ, Maclaren MC et al. (1986) Association of class II human histocompatibi-lity leukocyte antigens with rheumatic fever. J Clin Invest 77: 2019–2026

    Article  PubMed  CAS  Google Scholar 

  66. Maharaj B, Hammond MG, Appadoo B et al. (1987) HLA-A, B, DR and DO antigens in black patients with severe chronic rheumatic heart disease. Circulation 76: 259–261

    Article  PubMed  CAS  Google Scholar 

  67. Patarroyo ME, Winchester RJ, Vejerano A, et al. (1979) Association of a B-cell alloantigen with susceptibility to rheumatic fever. Nature 278: 173–174

    Article  PubMed  CAS  Google Scholar 

  68. Zabriskie JB, Lavenchy D, Williams RC Jr, Fu SM, Yeadon CA, Fontino M, Braun DG (1985) Rheumatic fever-associated B cell alloantigens as identified by monoclonal antibodies. Arthritis Rheum 28:1047 –1051

    Article  PubMed  CAS  Google Scholar 

  69. Khanna AK, Buskirk DR, Williams RC Jr et al. (1989) Presence of a non-HLA B cell antigen in rheumatic fever patients and their families as defined by a monoclonal antibody. J Clin Invest 83: 1710 - 1716

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag London Limited

About this chapter

Cite this chapter

Stollerman, G.H. (1990). Streptococci and Rheumatic Heart Disease. In: de Vries, R.R.P., Cohen, I.R., van Rood, J.J. (eds) The Role of Micro-organisms in Non-infectious Diseases. Argenteuil Symposia. Springer, London. https://doi.org/10.1007/978-1-4471-1796-4_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-1796-4_2

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-1798-8

  • Online ISBN: 978-1-4471-1796-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics